Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia (Q35096240)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia |
scientific article |
Statements
1 reference
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia (English)
1 reference
Jan H Beumer
1 reference
Ivana Gojo
1 reference
Ming Tan
1 reference
Hong-Bin Fang
1 reference
Mariola Sadowska
1 reference
Rena Lapidus
1 reference
Maria R Baer
1 reference
France Carrier
1 reference
Bean N Anyang
1 reference
Rakesh K Srivastava
1 reference
Igor Espinoza-Delgado
1 reference
Douglas D Ross
1 reference
12 February 2013
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference